Federation des caisses Desjardins du Quebec’s PTC Therapeutics PTCT Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-30	Closed	-$917	–	2667
2024 Q2	$917	Buy	+30	New	+$972	﹤0.01%	2198
2020 Q1	–	Sell	-4,790	Closed	-$230K	–	2327
2019 Q4	$230K	Sell	4,790 -363	-7%	-$15.4K	﹤0.01%	1015
2019 Q3	$174K	Sell	5,153 -369	-7%	-$16.1K	﹤0.01%	1124
2019 Q2	$248K	Buy	+5,522	New	+$218K	﹤0.01%	977
2018 Q2	–	Sell	-15,668	Closed	-$423K	–	2223
2018 Q1	$423K	Sell	15,668 -2,954	-16%	-$74.8K	0.01%	775
2017 Q4	$311K	Hold	18,622	–	–	﹤0.01%	927
2017 Q3	$373K	Buy	18,622 +7,255	+64%	+$142K	0.01%	828
2017 Q2	$208K	Buy	+11,367	New	+$153K	﹤0.01%	959

Other funds holding PTCT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PTCT Position: Q3 2024 in Review

Federation des caisses Desjardins du Quebec sold out of PTC Therapeutics (PTCT) in Q3 2024, closing a stake of 30 shares — an estimated $917 sold.

Federation des caisses Desjardins du Quebec first reported a position in PTCT in Q2 2017 and held it in 8 quarters. The position peaked at $423K in Q1 2018. 202 funds tracked by Wall St. Rank hold PTCT as of Q3 2024.

Federation des caisses Desjardins du Quebec reported no remaining PTC Therapeutics position as of Q3 2024 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 30 PTC Therapeutics shares in Q3 2024, an estimated $917.
Federation des caisses Desjardins du Quebec first reported a position in PTC Therapeutics in Q2 2017 and held it in 8 quarters.
Federation des caisses Desjardins du Quebec's PTC Therapeutics position peaked at $423K in Q1 2018.
202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2024, filed 13 Nov 2024.